Trana Discovery is an anti-infective drug discovery technology company that helps its partners find new classes of drugs for the treatment of bacterial, viral, and fungal infectious diseases. Our proprietary assays identify compounds that work through a unique mechanism of action: inhibition of the target pathogen’s ability to use transfer RNA (tRNA) essential for propagation.
The use of high-throughput screening assays developed by Trana Discovery will reduce the cost and time for drug discovery. Our company provides licensing opportunities for exclusive rights to new drug classes.
Specialties
drug discovery, drug discovery technology, assay, pharmaceutical, transfer ribonucleic acid, tRNA, infectious diseases, HIV, AIDS, Staphylococcus aureus, MRSA, tuberculosis, malaria, pneumonic plague, bubonic plague, yersina pestis, biodefense
